We have previously described an assay to quantify the serum neutralization of bacterial lipopolysaccharide which is based on a spectrophotometric Limulus amoebocyte lysate test (T. J. Novitsky, P. F. Roslansky, G. R. Siber, and H. S. Warren, J. Clin. Microbiol. 21:211-216, 1985). Studies since have shown that serum samples drawn from patients with leukemia and fever, gram-negative or gram-positive bacterial infections, or shock caused by gram-negative bacteria neutralize approximately 10-fold more lipopolysaccharide than do samples from normal controls. These findings suggested that the increased neutralization might reflect an acute-phase response and raised the question of whether it might be under the control of interleukin-1. To answer this question, we studied the neutralization of lipopolysaccharide in serum samples drawn from rabbits before and after the administration of crude interleukin-1, prepared from activated macrophage supernatants, and recombinant human interleukin-1. Crude interleukin-1 induced a 5.7-fold increase in serum neutralization 24 h after intravenous injection, and cloned interleukin-1 induced a 3.0-fold increase (P s 0.01 and 0.05, respectively). In individual rabbits given identical doses of crude interleukin-1 on a weight basis, the serum-neutralizing ability correlated significantly with three activities of interleukin-1: rise in temperature (r2 = 0.558; P s 0.01), decrease in serum iron (r2 = 0.534; P c 0.01), and increase in serum copper (r2 = 0.323; P s 0.05). We conclude that the increase in neutralization of bacterial lipopolysaccharide by serum samples drawn from patients with inflammatory states is mediated, at least in part, by interleukin-1, presumably through the induction of acute-phase serum proteins.
For the last 50 years there has been interest in host mechanisms of protection against the toxic effects of bacterial lipopolysaccharide (LPS). Early studies used LPSinduced fever as a convenient biological assay, and it was reported that rabbits rapidly became tolerant to LPS. Careful studies revealed that there are two phases of pyrogenic tolerance to LPS, an early nonspecific phase that is present from 8 h to 6 days and a late phase that is specific to the LPS strain and coincides with the appearance of antibody directed to the polysaccharide moiety of LPS (5) . Passive transfer of tolerance by large quantities of serum in the absence of anti-LPS antibodies has also been reported (4, 6, 15) , suggesting that a factor exists in early-phase tolerant serum capable of augmenting the neutralization of heterologous LPS. The elucidation and control of the mechanisms involved in this phenomenon are of practical interest because they could perhaps be manipulated for prophylactic or therapeutic advantage.
We have recently described a sensitive and quantitative assay for measuring the serum neutralization of LPS (8) . The assay is based on the ability of serum to inhibit the effects of LPS on Limulus amoebocyte lysate (LAL ization of LPS by serum, thus permitting its use as a method for quantitating LPS detoxification (14) .
Using this assay, we have found that all rabbit sera neutralize LPS but that serum samples drawn from rabbits 24 h after the induction of tolerance neutralize increased amounts of homologous and heterologous LPS (13a) . Another study demonstrated that human serum samples from patients with leukemia and fever or clinically diagnosed shock caused by gram-negative bacteria neutralize more LPS than do samples from normal control patients or patients with cardiogenic shock (14a). These findings suggested to us that the augmented detoxification of LPS by these sera may represent an acute-phase response by the host. Many acute-phase factors, including serum amyloid A, C-reactive protein, and fibrinogen are regulated, at least in part, by interleukin-1 (IL-1) (1). We therefore studied the effect of intravenous administration of IL-1 on the ability of serum to neutralize LPS, as measured by the Limulus assay. We report here that activated macrophage supernatants containing IL-1 and human recombinant IL-1 (rHuIL-1) administered to rabbits induced increased serum neutralization of LPS.
MATERIALS AND METHODS
Preparation of celis. Rabbit peritoneal exudates were induced by an intraperitoneal injection of 50 ml of sterile mineral oil. The rabbits were sacrificed 72 h later by administration of an intravenous overdose of pentobarbital, and peritoneal exudate cells (PEC) were harvested from the peritoneal cavity by using 300 ml of heparinized ( 20 assessed for their pyrogenic activity and the ability to alter iron and copper concentrations in serum (10) . As expected, both crude IL-1 and rHuIL-1 were pyrogenic and induced a significant decrease in serum iron and increase in serum copper (Table 1) . Effect of crude IL-1 and rHuIL-l on serum neutralizing ability. Both crude IL-1 and rHuIL-1 induced a significant increase in serum LR50 8 and 24 h after intravenous injection (P < 0.01 for crude IL-1 and P < 0.05 for rHuIL-1 at each time [Mann-Whitney two-tailed test]) (Fig. 2) . For each preparation the increase in the LR50 was significantly greater at 24 h than at 8 h (P < 0.01 [Mann-Whitney two-tailed test]).
Crude IL-1 administered at 1.0 ml/kg appeared to be more active in augmenting the LR50 than was cloned IL-1 administered at 10 ,ug/kg. This difference in potency cannot be interpreted because there were probably numerous monokines in our crude macrophage supernatants and because the biological activity of the recombinant preparation was possibly diminished during expression, extraction, and purification.
Correlation of LPS-neutralizing activity with pyrogenicity and change in metal concentrations in serum after injection of activated macrophagç supernatants. Since the rise in temperature and change in metal levels in serum varied considerably in different rabbits despite an identical dose of crude macrophage supernatant (administered on a weight basis), it was of interest to determine whether these parameters correlated with the increase in serum LR50. The correlation analysis was performed as described in Materials and Methods at the time of maximal change for each parameter. The increase in LR50 at 24 h correlated significantly with maximal rise in temperature (r2 = 0.558; P < 0.01; 12 df), decrease in serum iron at 8 h (r2 = 0.534; P < 0.01; 12 df), and increase in serum copper at 24 h (r2 = 0.323; P < 0.05; 10 dfO in the 14 rabbits studied.
DISCUSSION
Our data provide direct evidence that the neutralization of LPS by serum is augmented by administration of activated macrophage supernatants and rHuIL-1, at least as measured by inhibition of LAL. Notably, the neutralization correlated with three different activities of IL-1 in rabbits given identical doses of activated macrophage supernatants. Further work will be needed to determine whether the neutralization is a direct or indirect (e.g., fever mediated) effect of IL-1. Whichever is the case, IL-1 would seem to be the perfect mediator for the serum neutralization of LPS from a teleological and homeostatic point of view. We have previously shown that LPS incubated in fresh frozen human plasma screened for high LR50 induces less fever in the rabbit pyrogen test than does LPS incubated in plasma screened for low LR50 (14) . We hypothesize that LPS stimulates macro- phages to produce IL-1 (and perhaps other factors such as tumor necrosis factor or hepatocyte-stimulating factor [16] ), which then induces a change in serum such that it is capable of neutralizing greater amounts of LPS. Thus, there appears to be a macrophage-based mechanism for decreasing the induction of IL-1 by subsequent LPS challenge or continued LPS circulation.
The neutralization mechanism is under study. Several pieces of evidence suggest that the binding of LPS to serum lipoproteins may be important. Procedures that remove lipoproteins from serum, such as chloroform extraction (3) or ultracentrifugation (H. S. Warren, unpublished data), decrease the serum neutralization of LPS in the LAL assay. Delipidation by ether extraction removes the abiity of serum to neutralize LPS in the rabbit pyrogen assay, whereas reconstitution with lipoproteins restores it (13) . Radiolabeled LPS binds to serum lipoproteins in a time-and temperaturedependent manner (12) , and LPS bound to lipoprotein is much less active than unbound LPS in numerous assay systems, including the induction of fever (7, 12) and LAL activation (7) . In addition, the rate of binding of E. coli 0113 LPS to lipoproteins and the neutralization of LPS in the LAL assay are both increased in serum samples drawn from tolerant rabbits (13a) . A different possibility is that an acute-phase protein stimulated by IL-1 is responsible for the neutralization. A 60-kilodalton glycoprotein has recently been found in acute-phase sera that binds to LPS extracted from the rough mutant Salmonella minnesota Re595 and delays its binding to serum lipoproteins (11) . It (4, 6, 15) . Our data raise the question of whether the serum factor responsible in these studies was induced by repetitive bursts of LPS-stimulated IL-1 and provide further evidence that passive transfer of such resistance may be possible.
